These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25447870)

  • 41. Prediction of inclusion body solubilization from shaken to stirred reactors.
    Walther C; Mayer S; Trefilov A; Sekot G; Hahn R; Jungbauer A; Dürauer A
    Biotechnol Bioeng; 2014 Jan; 111(1):84-94. PubMed ID: 23860724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solubilization of inclusion body proteins using n-propanol and its refolding into bioactive form.
    Singh SM; Sharma A; Upadhyay AK; Singh A; Garg LC; Panda AK
    Protein Expr Purif; 2012 Jan; 81(1):75-82. PubMed ID: 21964443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of high pressure and alkaline condition for solubilization of inclusion bodies and refolding of the NS1 protein from zika virus.
    Rosa da Silva CM; Chura-Chambi RM; Ramos Pereira L; Cordeiro Y; de Souza Ferreira LC; Morganti L
    BMC Biotechnol; 2018 Dec; 18(1):78. PubMed ID: 30541520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
    Panda AK
    Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Solubilization and refolding with simultaneous purification of recombinant human stem cell factor.
    Wang C; Liu J; Wang L; Geng X
    Appl Biochem Biotechnol; 2008 Feb; 144(2):181-9. PubMed ID: 18456949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.
    Cabrita LD; Bottomley SP
    Biotechnol Annu Rev; 2004; 10():31-50. PubMed ID: 15504702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacterial Inclusion Bodies: A Treasure Trove of Bioactive Proteins.
    Singhvi P; Saneja A; Srichandan S; Panda AK
    Trends Biotechnol; 2020 May; 38(5):474-486. PubMed ID: 31954528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality control of inclusion bodies in Escherichia coli.
    Jürgen B; Breitenstein A; Urlacher V; Büttner K; Lin H; Hecker M; Schweder T; Neubauer P
    Microb Cell Fact; 2010 May; 9():41. PubMed ID: 20509924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mammalian G protein-coupled receptor expression in Escherichia coli: II. Refolding and biophysical characterization of mouse cannabinoid receptor 1 and human parathyroid hormone receptor 1.
    Michalke K; Huyghe C; Lichière J; Gravière ME; Siponen M; Sciara G; Lepaul I; Wagner R; Magg C; Rudolph R; Cambillau C; Desmyter A
    Anal Biochem; 2010 Jun; 401(1):74-80. PubMed ID: 20175983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A magic agent in protein refolding: arginine].
    Arakawa T; Katsuyama I; Kumagai I; Tsumoto K
    Tanpakushitsu Kakusan Koso; 2003 Dec; 48(16):2310-7. PubMed ID: 14661589
    [No Abstract]   [Full Text] [Related]  

  • 51. Kinetics of inclusion body formation and its correlation with the characteristics of protein aggregates in Escherichia coli.
    Upadhyay AK; Murmu A; Singh A; Panda AK
    PLoS One; 2012; 7(3):e33951. PubMed ID: 22479486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
    Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
    Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intensification of Inclusion Body Processing via Temperature-Based Refolding.
    Wong RS; Alias NNM; Ong EBB; Liew MWO
    Methods Mol Biol; 2023; 2617():189-200. PubMed ID: 36656525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional protein aggregates: just the tip of the iceberg.
    Villaverde A; Corchero JL; Seras-Franzoso J; Garcia-Fruitós E
    Nanomedicine (Lond); 2015; 10(18):2881-91. PubMed ID: 26370294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-reducing alkaline solubilization and rapid on-column refolding of recombinant prion protein.
    Walsh DJ; Noble GP; Piro JR; Supattapone S
    Prep Biochem Biotechnol; 2012; 42(1):77-86. PubMed ID: 22239709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soni-removal of nucleic acids from inclusion bodies.
    Neerathilingam M; Mysore S; Gandham SH
    Biochem Biophys Res Commun; 2014 May; 448(1):45-9. PubMed ID: 24747565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
    Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
    J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dynamic transcriptional response of Escherichia coli to inclusion body formation.
    Baig F; Fernando LP; Salazar MA; Powell RR; Bruce TF; Harcum SW
    Biotechnol Bioeng; 2014 May; 111(5):980-99. PubMed ID: 24338599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2.
    Esfandiar S; Hashemi-Najafabadi S; Shojaosadati SA; Sarrafzadeh SA; Pourpak Z
    Biotechnol Appl Biochem; 2010 Apr; 55(4):209-14. PubMed ID: 20236092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Technical refolding of proteins: Do we have freedom to operate?
    Eiberle MK; Jungbauer A
    Biotechnol J; 2010 Jun; 5(6):547-59. PubMed ID: 20518058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.